9 Pillars Of Inspection Readiness For GMP Manufacturers: A Practical CSA Playbook

Scrambling for records, chasing down technicians, and assembling asset history by hand point to a system problem, not an inspection problem. With FDA's risk-based enforcement and continued attention to data integrity, readiness has to be a standing condition. This framework (the author's own, not an official FDA model) sorts inspection readiness into nine pillars that correspond to areas inspectors actually examine. They run from leadership and CAPA maturity, through process, facility, equipment, and lab controls, to how people and mock audits perform under pressure. Throughout, it singles out where maintenance, calibration, and asset records weigh most heavily, and it links to a self-assessment for benchmarking your current state. Explore the nine pillars to see where your program stands.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.